Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 22, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	45	139	271	132	106	36
Market Cap Growth	-63.35%	-48.69%	104.97%	24.94%	195.56%	-19.92%
Enterprise Value	-32	58	162	51	59	23
Last Close Price	1.45	5.08	10.65	6.01	7.80	6.53
PS Ratio	723.09	1719.26	263.49	115.74	-	-
PB Ratio	1.18	3.83	4.08	1.80	1.73	6.35
P/TBV Ratio	1.53	3.83	4.08	1.80	1.73	6.35
P/FCF Ratio	-	-	32.79	-	-	-
P/OCF Ratio	-	-	31.40	-	-	-
EV/Sales Ratio	-	722.14	157.46	44.40	-	-
EV/FCF Ratio	-	-	19.59	-	-	-
Debt / Equity Ratio	0.04	0.06	0.04	0.00	0.01	0.25
Debt / FCF Ratio	-	-	0.31	-	-	-
Asset Turnover	0.00	0.00	0.01	0.02	-	-
Quick Ratio	10.14	9.03	10.25	11.38	13.33	1.73
Current Ratio	10.25	9.21	10.44	11.66	13.62	1.89
Return on Equity (ROE)	-100.05%	-94.92%	-47.16%	-36.74%	-66.35%	-302.97%
Return on Assets (ROA)	-32.85%	-33.17%	-21.91%	-21.26%	-35.86%	-103.88%
Return on Capital (ROIC)	-65.57%	-60.34%	-29.83%	-22.96%	-40.49%	-170.86%
Earnings Yield	-90.45%	-35.06%	-12.17%	-18.71%	-20.96%	-61.08%
FCF Yield	-76.98%	-34.10%	3.05%	-15.86%	-20.64%	-60.04%
Buyback Yield / Dilution	-11.51%	-10.20%	-17.37%	-69.51%	-143.87%	-40.77%
Total Shareholder Return	-11.51%	-10.20%	-17.37%	-69.51%	-143.87%	-40.77%

Source: S&P Capital IQ. Standard template. Financial Sources.